Abstract: Diabetes-specific formulas have shown to be effective at improving glucose control with additional nutritional benefits. Furthermore, diabetes-specific formulas are commonly used for diabetic patients with insufficient oral intake. However, not much diabetes-specific formulas in the market shows the GI of these formulas, which is clinically useful on glycemic control in patients with diabetes. The aim of this study was to assess the GI of a newly developed diabetes-specific formula, Contro eazy NOW. The open labelled, single center study involved 11 individuals from a pool of 18 healthy subjects. After an overnight fast, volunteers were given Contro eazy NOW containing 50g of carbohydrate or the reference drink (glucolin) on different occasions in random order. Postprandial blood glucose levels were measured in finger pricked capillary blood for two hours after intake of the beverages and positive incremental area under the curve (AUC) was calculated for both Contro eazy NOW and reference drink. The GI of Contro eazy NOW was determined by dividing AUC (Contro eazy NOW) by the AUC (reference drink). The results show that the diabetes-specific formula has the GI of 38.4, which is categorized as low GI. Therefore, Contro eazy NOW with low GI can be the preferred option for nutritional management of diabetic patients in need of nutritional support.
Keywords: diabetes-specific formula, diabetes, low glycemic index, medical nutrition therapy.
Title: Evaluation of Postprandial Glycemic Response on Diabetes-Specific Formula
Author: Alicia Wong, Wan Chien Han, Elsie Low, Chai Xiang Goh, Siew Li Ng, Lee Kuan Kwan
International Journal of Social Science and Humanities Research
ISSN 2348-3156 (Print), ISSN 2348-3164 (online)
Research Publish Journals
